FDA grants clearance for Sorrento Phase II/III Covid-19 therapy trial
Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.
Source: clinicaltrialsarena.com
Page 6 - Preference Management Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Preference Management Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Preference Management Solution Today - Breaking & Trending Today
Tiziana commences Phase Ib trial of Crohn's disease antibody
Tiziana Life Sciences has commenced a Phase Ib trial of oral enteric-coated capsules of foralumab for treating Crohn’s disease patients.
Source: clinicaltrialsarena.com
Pfizer to halt new clinical trial initiations in Russia amid Ukraine crisis
Pfizer has announced that the company will not commence any new clinical trials in Russia amid the Ukraine crisis.
Source: clinicaltrialsarena.com
Can Russia cope without Taiwan's semiconductors? Investment Monitor
Russia is dependent on Taiwan's semiconductors for everything from the manufacture of laptops to military equipment.
Source: clinicaltrialsarena.com
DiscGenics reports positive data from degenerative disc disease trial
DiscGenics has reported positive interim results from its Phase I/II trial of IDCT (rebonuputemcel) to treat degenerative disc disease.
Source: clinicaltrialsarena.com